USPTO serial 79271664
Y BIOLOGICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- TULLY, MATTHEW
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with Y BIOLOGICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibodies; antibodies for medical purposes; bispecific antibodies; bispecific antibodies for medical purposes; pharmaceuticals; antibody medicines; antibody reagents for medical purposes; antibody library; antibody library for medical purposes | ACTIVE | — |
| 035 | Wholesale store services featuring antibodies; retail store services featuring antibodies; wholesale store services featuring bispecific antibodies; retail store services featuring bispecific antibodies; wholesale store services featuring antibodies for medical purposes; retail store services featuring antibodies for medical purposes; wholesale store services featuring bispecific antibodies for medical purposes; retail store services featuring bispecific antibodies for medical purposes; wholesale store services services featuring pharmaceuticals for human purposes; retail store services featuring pharmaceuticals for human purpose | ACTIVE | — |
| 042 | Drug discovery services; research relating to pharmaceuticals; development of pharmaceuticals; research in the field of medical products; medicine research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of antibodies; research and development of bispecific antibodies; development of antibody library; screening services relating to antibodies; screening services relating to antibodies for development of pharmaceuticals; research and development relating to biotechnology; biotechnology services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Aug 14, 2021 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 10, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 2, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 27, 2020 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 27, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |